SARS-CoV-2 and risk of psychiatric hospital admission and use of psychopharmaceuticals: A nationwide registry study of 4,585,083 adult Danish citizens

BACKGROUND: Current evidence on the risk of admission- or medication-requiring psychiatric sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is limited to selected populations, short durations, and loss to follow-up. This study examined if SARS-CoV-2 infection was as...

Descripción completa

Detalles Bibliográficos
Autores principales: Rømer, Valdemar, Sivapalan, Pradeesh, Eklöf, Josefin, Nielsen, Susanne D., Harboe, Zitta B., Biering-Sørensen, Tor, Itenov, Theis, Jensen, Jens-Ulrik S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305760/
https://www.ncbi.nlm.nih.gov/pubmed/37282564
http://dx.doi.org/10.1192/j.eurpsy.2023.2418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305760/
https://www.ncbi.nlm.nih.gov/pubmed/37282564
http://dx.doi.org/10.1192/j.eurpsy.2023.2418

Ejemplares similares